Moreover, over-expression of the human AGT protein (hAGT) in cancer cells is frequently associated with resistance to alkylating chemotherapy; for this reason, chemotherapy regimens of O6-BG in combination with alkylating agents are in clinical development13,16. Here, AGT is linked to cancer.